Veeva Systems, a leading provider of cloud-based software, data, and consulting services for the life sciences industry, has announced a strategic collaboration with biotechnology giant Amgen to advance clinical trial innovation. Under the partnership, Amgen will adopt the Veeva Clinical Platform to streamline and optimize its clinical trial processes, reinforcing its commitment to accelerating the development of new treatments for serious diseases.

“In collaboration with Veeva, we’re leveraging advanced technology to unlock new capabilities for our end-to-end trial operations which are expected to further strengthen our ability to bring innovative treatments to patients with speed and scale,” said Scott Skellenger, senior vice president and chief information officer at Amgen.

Jim Reilly, president of Veeva Development Cloud, added, “We’re excited to help Amgen further advance clinical development. Veeva Clinical Platform will provide the backbone for standard and connected processes that can speed the delivery of life-saving drugs to patients in need.”

The collaboration will also see Veeva Business Consulting support Amgen with implementation and change management.

Veeva Clinical Platform is an integrated system that connects clinical operations and data applications, including CTMS, EDC, CDB, RTSM, eCOA, eTMF, Site Connect, and Study Training. By automating data flow and simplifying processes from trial start-up to close, the platform enhances efficiency and accelerates outcomes.

Veeva currently serves over 1,500 customers worldwide, from large pharmaceutical firms to emerging biotechs, with a focus on innovation, product excellence, and customer success.